“Academic.” Twitter equivalent of a “reply all” email thread
Jun 11, 2022 • 17 tweets • 6 min read
1/ Ok. In light of @ABCTNOW#apologygate, I’m going to try to help with #scicomm on a paper that informs my rubric of how to apologize. (#science). This paper breaks apology components into 6 bits. Two seem most effective, but overall *more is better* onlinelibrary.wiley.com/doi/abs/10.111…2/ First, acknowledge what you *did* wrong (i.e., take responsibility). If what you want to discuss is people’s feelings or reactions, you’re not sorry about what you did, you’re sorry about its aftermath. Literally, own up to what YOU did in concrete terms.
Jun 9, 2022 • 5 tweets • 2 min read
I have THOUGHTS. Some on how some therapy orientations get a pass in criticism but more on ABCT having a statement signed by its presidents when at least two (Barlow and Hayes) have published papers on behavioral modification of sexuality
2/ I realize that the apology references how “membership in prominent leadership roles” have contributed to this nonsense parading as science but it’s funny those people aren’t specifically named.
Feb 2, 2022 • 12 tweets • 3 min read
1/ Thanks @DepressionLab . Paper needs a better title but it describes disatisfaction I've had for some time with our treatment research. A thread 🥁A big one is that we got used to doing 1-2 treatment clinical trials with 8-16 week endpoints. But, all of this is arbitrary!
2/ Most people who make it to treatment studies require more than 1 treatment to get better. We need to study this sequencing process+. Easy to criticize STAR*D (in fact, I do here) but at least that's one thing it got right: treatment is dynamic and should be studied as such.
Oct 2, 2021 • 7 tweets • 2 min read
🤞Don’t wanna become the #AcademicTwitter main character but I started the “30 minutes of writing” thing again for the past 3 weeks and it’s been super helpful. Recommend. It’s a challenge on days I only have 1 hour of unscheduled time or so but I’ve reframe it as X time-30
2/ First, it puts in perspective that I’m leading 6 papers so I don’t want to start another as lead. In the past I’ve said to myself “I have noting to write” but it’s more that it’s easy to lose sight of projects if you don’t work on them daily. Second, if you are the kind of
Aug 5, 2021 • 8 tweets • 2 min read
1/ I wouldn't recommend listening to this. I did thinking there'd be an apology. There wasn't and she refused directly when asked. I'm writing as I'm reading it. The overall take "it's more complicated" is empty when the complicating factors wouldn't change the interpretation
2/ It is contextualizing her as being scared of being alone with Christian Cooper adding context like she may be immunocompromised or she was sexually assaulted. There are also implications that the event was framed as racist *because* of #GeorgeFloyd
Jun 14, 2021 • 10 tweets • 2 min read
Could you help get Aaron Beck recognized as the Google Doodle feature for his birthday, July 18?
Here’s what you can do: Submit a request to Google (which will probably take under a minute).
You can either cut and paste the message below and send it to doodleproposals@google.com
2/ or submit your own. Below:
I am writing to submit an idea for a Google Doodle for July 18th, 2021.
On July 18th the scientific, medical, and mental health communities around the world will celebrate the 100th birthday of Dr. Aaron T. Beck. Dr. Beck is globally
May 31, 2021 • 11 tweets • 3 min read
I think controls needs to be thought of in a more intentional way. It’s not “waiting lists are bad even if you call it care as usual” and “always use a psych placebo.” To be clear, the absolute response or remission rates are not higher in studies using
2/ weak controls or that the outcomes in psychotherapies behave differently in these trials. It’s that the more inert the control is the bigger the treatment-control difference is. This is not (just) a pedantic point because there are reasons to think carefully about the controls
